Acute phase serum amyloid A, cholesterol metabolism, and cardiovascular disease

Pediatric Pathology and Molecular Medicine

Volumn 21, Issue 3, 2002, Pages 291-305

  Kisilevsky, Robert ^a   Tam, Shui Pang ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Acute phase proteins; Atherogenesis; Cardiovascular disease; Cholesterol metabolism; HDL; High density lipoprotein; Inflammation; Macrophages; Physiological function; Serum amyloid A

Indexed keywords

AMYLOID A PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; ACUTE PHASE PROTEIN; APOLIPOPROTEIN; SERUM AMYLOID A;

ACUTE PHASE RESPONSE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CHOLESTEROL METABOLISM; HUMAN; INFLAMMATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; REVIEW; UNSTABLE ANGINA PECTORIS; ARTERIOSCLEROSIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACUTE-PHASE PROTEINS; AMYLOID PROTEIN AA; APOLIPOPROTEINS; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL; HUMAN; SUPPORT, NON-U.S. GOV'T; HUMANS; SERUM AMYLOID A PROTEIN;

EID: 0036016553     PISSN: 15227952     EISSN: None     Source Type: Journal    
DOI: 10.1080/02770930290056523     Document Type: Review

References (102)

1. Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits
2. Prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
3. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury
4. Serum amyloid A changes high density lipoprotein's cellular affinity: A clue to serum amyloid A's principal function
5. Serum amyloid A (SAA): Influence on HDL-mediated cellular cholesterol efflux
6. Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse
7. Acute phase serum amyloid a protein increases high density lipoprotein binding to human peripheral blood mononuclear cells and an endothelial cell line
8. Evolution of the serum amyloid A (SAA) protein superfamily
9. Acute phase proteins in salmonids - Evolutionary analyses and acute phase response
10. Amino acid sequence of amyloid-related apoprotein (apoSAA1) from human high-density lipoprotein
11. The complete amino-acid sequence of non-immunoglobulin amyloid fibril protein AS in Rheumatoid arthritis
12. The primary structure of serum amyloid-A protein in the sheep - Comparison with serum amyloid-A in other species
13. Structure of the murine serum amyloid A gene family. Gene conversion
14. Differential expression of the amyloid SAA gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes
15. Expression of the thud member of the serum amyloid A gene family in mouse adipocytes
16. Localization of human SAA gene(s) to chromosome II and detection of DNA polymorphisms
17. Genes for serum amyloid-A proteins map to chromosome-7 in the mouse
18. Identification of novel members of the serum amyloid-A protein superfamily as constitutive apolipoproteins of high density lipoprotein
19. Mouse serum amyloid A protein [SAA(5)] structure and expression
20. Characterization of constitutive human serum amyloid A protein (SAA(4)) as an apolipoprorein
21. Murine serum amyloid-A(3) is a high density apolipoprotein and is secreted by macrophages
22. The acute phase response: General aspects
23. Kinetics of SAP and SAA production by cultured mouse liver cells
24. Murine tissue amyloid protein AA: NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products
25. Characterization of amyloid A protein in human secondary amyloidosis: The predominant deposition of serum amyloid A1
26. Acute phase response of serum amyloid A protein and C-reactive protein to the common cold and influenza
27. Serum amyloid A (SAA) variations in patients with cancer: Correlation with disease activity, stage, primary site, and prognosis
28. Serum amyloid A protein in amyloidosis, rheumatic and neoplastic diseases
29. Experimental amyloidosis: Studies with a modified casein method, casein hydrolysate and gelatin
30. Time course of serum amyloid-A response in myocardial infarction
31. Serum amyloid A protein in patients with acute myocardial infarction
32. Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction
33. Induction of hepatic synthesis of serum amyloid A protein and actin
34. Changes in human serum amyloid-A and C-reactive protein after etiocholanolone-induced inflammation
35. Constitutive and NF-kappaB like proteins in the regulation of the serum amyloid-A gene by interleukin-1
36. Mechanism of minimally modified LDL-mediated induction of serum amyloid A gene in monocyte/macrophage cells
37. Activation of Spl and its functional co-operation with serum amyloid A-activating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression
38. Induction of human serum amyloid A in Hep 3B cells by IL-6 and IL-1 beta involves both transcriptional and post-transcriptional mechanisms
39. Biosynthesis of human acute-phase serum amyloid A-protein (A-SAA) in vitro-the roles of messenger RNA accumulation, poly(A) tail shortening and translational efficiency
40. Differential induction of the serum amyloid-A gene family in response to an inflammatory agent and to amyloid-enhancing factor
41. Amyloid A: Amphipathic helixes and lipid binding
42. Amyloid protein SAA is associated with high density lipoprotein from human serum
43. Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein
44. Serum amyloid A-containing human high density lipoprotein 3: Density, size, and apolipoprotein composition
45. Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoproteins (HDL). Displacement of SAA from the HDL-SAA complex by apoA-I and apoA-II
46. Serum amyloid A protein generates pre β 1 high-density lipoprotein from α-migrating high-density lipoprotein
47. Molecular physiology of reverse cholesterol transport-review
48. SAA-only HDL formed during the acute phase response in apoA-I +/+ and apoA-I -/- mice
49. Apolipoprotein-A-I and apolipoprotein SAA half-lives during acute inflammation and amyloidogenesis
50. Serum amyloid A protein in plasma: Characteristics of acute phase HDL
51. Secondary structure prediction of human SAA1 presumptive identification of calcium and lipid binding sites
52. Amyloid deposits and amyloidosis. The B-fibrilloses. Part I and II
53. A fusion protein between serum amyloid A and staphylococcal nuclease-synthesis, purification, and structural studies
54. Secretion of serum amyloid protein and assembly of serum amyloid protein-rich high density lipoprotein in primary mouse hepatocyte culture
55. Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis
56. 3+ as a specific probe for time-resolved fluorometric immunoassay
57. Mapping of antigenic determinants of purified, lipid-free human serum amyloid A proteins
58. Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells
59. Inhibition of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A-toward understanding the physiological role of an enigmatic protein
60. The effect of serum amyloid protein A fragment-SAA (25-76) on blood platelet aggregation
61. Serum amyloid-A, an acute phase protein, inhibits platelet activation
62. Serum amyloid A (SAA) protein enhances formation of cyclooxygenase metabolites of activated human monocytes
63. Binding of human serum amyloid A (hSAA) and its high-density lipoprotein(3) complex [hSAA-HDL (3)] to human neutrophils - Possible implication to the function of a protein of an unknown physiological role
64. The heparin/heparan sulfate-binding site on apo-serum amyloid A: Implications for the therapeutic intervention of amyloidosis
65. Binding and endocytosis of high density lipoprotein from healthy (HDL) and inflammed (HDLsaa) donors by murine macrophages in-vitro. A light and electronmicroscopic investigation
66. SAA suppression of immune response in vitro: Evidence for an effect on T cell-macrophage interaction
67. Serum amyloid A is a chemoattractant: Induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes
68. A novel biologic function of serum amyloid A-induction of T lymphocyte migration and adhesion
69. Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion
70. Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4(+) T cells
71. Effects of serum amyloid-A protein on lymphocytes, HeLa, and Mrc5 cells in culture
72. Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein
73. The human serum amyloid-A (SAA)-encoding gene Gsaalnucleotide sequence and possible autocrine-collagenase-inducer function
74. Serum amyloid-A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin-1 induces synthesis of collagenase and is neutralized with specific antiserum
75. Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A(2)
76. Influence of serum amyloid-A on cholesterol esterification in human plasma
77. Reverse cholesterol transport in the isolated perfused rat spleen
78. Reverse Cholesterol transport in the rat-studies using the isolated perfused spleen in conjunction with the perfused liver
79. Serum amyloid-A (SAA), a protein without a function - Some suggestions with reference to cholesterol metabolism
80. Acute phase serum amyloid A (SAA) and cholesterol transport during acute inflammation: A hypothesis
81. Inflammation
82. Determination of membrane cholesterol in normal and pathological red blood cells
83. Influence of increased membrane cholesterol on membrane fluidity and cell function in human red blood cells
84. A longitudinal analysis of alteration in lecithin-cholesterol acyltransferase and paraoxonase activities following laparoscopic cholecystectomy relative to other parameters of HDL function and the acute phase response
85. A seventransmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells
86. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages
87. Colocalization of ubiquitin and serum amyloid A and ubiquitin-bound AA in the endosomes-lysosomes: A double immunogold electron microscopic study
88. Recombinant human serum amyloid A [apoSAA (p)] binds cholesterol and modulates cholesterol flux
89. Serum amyloid A influences the efflux of cholesterol from macrophages
90. Serum amyloid A has little effect on high density lipoprotein (HDL) binding to U937 monocytes but may influence HDL mediated cholesterol transfer
91. The acute phase response in Syrian hamsters elevates apolipoprotein serum amyloid A (apoSAA) and disrupts lipoprotein metabolism
92. Expression ofapolipoprotein serum amyloid-A messenger RNA in human atherosclerotic lesions and cultured vascular cells-implications for serum amyloid-A function
93. Infection and inflammation-induced proatherogenic changes of lipoproteins
94. Anti-inflammatory HDL becomes proinflammatory during the acute phase response-loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures
95. The pathogenesis of atherosclerosis: Atherogenesis and inflammation
96. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease
97. C-reactive protein, inflammation, and coronary risk
98. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
99. Heat production of atherosclerotic plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes
100. Vascular system
101. Does serum amyloid A mobilize cholesterol from macrophages during inflammation
102. Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis